| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |